These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 26001244)

  • 21. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
    Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH
    Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
    Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
    Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching.
    Min YW; Lee JH; Gwak GY; Paik YH; Lee JH; Rhee PL; Koh KC; Paik SW; Yoo BC; Choi MS
    J Gastroenterol Hepatol; 2014 May; 29(5):1043-8. PubMed ID: 24863186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China.
    Huang ZY; Liang BY; Xiong M; Zhan DQ; Wei S; Wang GP; Chen YF; Chen XP
    Ann Surg Oncol; 2012 Aug; 19(8):2515-25. PubMed ID: 22395985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
    Minagawa M; Makuuchi M; Takayama T; Kokudo N
    Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
    Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
    Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
    World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma.
    Zhu SL; Zhong JH; Ke Y; Ma L; You XM; Li LQ
    World J Gastroenterol; 2015 Aug; 21(32):9630-7. PubMed ID: 26327771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis.
    Seehofer D; Nebrig M; Denecke T; Kroencke T; Weichert W; Stockmann M; Somasundaram R; Schott E; Puhl G; Neuhaus P
    Clin Transplant; 2012; 26(5):764-74. PubMed ID: 22432589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
    Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
    AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series.
    Terzi E; Terenzi L; Venerandi L; Croci L; Renzulli M; Mosconi C; Allegretti G; Granito A; Golfieri R; Bolondi L; Piscaglia F
    Dig Dis; 2014; 32(6):711-6. PubMed ID: 25376288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome.
    Chen WT; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
    Eur J Surg Oncol; 2004 May; 30(4):414-20. PubMed ID: 15063895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
    Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
    Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
    Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
    Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.